Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Capital Expenditures: 2012-2024

Historic Capital Expenditures for Tg Therapeutics (TGTX) over the last 12 years, with Dec 2024 value amounting to $45,000.

  • Tg Therapeutics' Capital Expenditures rose 233.33% to $80,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $168,000, marking a year-over-year increase of 342.11%. This contributed to the annual value of $45,000 for FY2024, which is N/A change from last year.
  • Tg Therapeutics' Capital Expenditures amounted to $45,000 in FY2024, which was up 221.43% from $14,000 recorded in FY2022.
  • In the past 5 years, Tg Therapeutics' Capital Expenditures registered a high of $401,000 during FY2021, and its lowest value of $14,000 during FY2022.
  • For the 2-year period, Tg Therapeutics' Capital Expenditures averaged around $29,500, with its median value being $29,500 (2022).
  • Per our database at Business Quant, Tg Therapeutics' Capital Expenditures spiked by 172.52% in 2020 and then plummeted by 96.51% in 2022.
  • Yearly analysis of 4 years shows Tg Therapeutics' Capital Expenditures stood at $357,000 in 2020, then increased by 12.32% to $401,000 in 2021, then plummeted by 96.51% to $14,000 in 2022, then reached $45,000 in 2024.